A critical review of microplastics toxicity and potential adverse outcome pathway in human gastrointestinal tract following oral exposure.


Journal

Toxicology letters
ISSN: 1879-3169
Titre abrégé: Toxicol Lett
Pays: Netherlands
ID NLM: 7709027

Informations de publication

Date de publication:
15 Aug 2023
Historique:
received: 28 04 2023
revised: 21 08 2023
accepted: 29 08 2023
medline: 13 9 2023
pubmed: 3 9 2023
entrez: 2 9 2023
Statut: ppublish

Résumé

Microplastics (MPs) are typically produced via environmental degradation of larger plastics, where they enter the human food chain. MPs are complex materials containing chemical and physical characteristics that can potentially affect their hazard and exposure. These physical properties can be altered by environmental exposure potentially altering any risk assessment conducted on the primary material. We conducted a literature review using an Adverse Outcome Pathway (AOP)-based approach from Molecular Initiating Event (MIE) to cell effect event to identify multiple knowledge gaps that affect MPs hazard assessment. There is some convergence of key biological events but could relate to most lying along well-established biological effector pathways such as apoptosis which can respond to many MIEs. In contrast, MIEs of chemicals will be via protein interaction. As MPs may occur in the lumen of the alimentary canal for example to the mucus, therefore, not requiring translocation of MPs across the epithelial membrane. At the other end of the AOP, currently it is not possible to identify a single adverse outcome at the organ level. This work did establish a clear need to understand both external and internal exposure (resulting from translocation) and develop hazard data at both levels to inform on risk assessments.

Identifiants

pubmed: 37659479
pii: S0378-4274(23)00255-2
doi: 10.1016/j.toxlet.2023.08.011
pii:
doi:

Substances chimiques

Microplastics 0
Plastics 0

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

51-60

Informations de copyright

Crown Copyright © 2023. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Lorna Jones reports financial support was provided by National institute of Health Research.

Auteurs

Lorna R Jones (LR)

UK Health Security Agency. Toxicology Department, Harwell Campus, Oxfordshire, United Kingdom; Environmental Research Group, Imperial College London, United Kingdom; Health Protection Research Unit in Environmental Exposures and Health, United Kingdom. Electronic address: lorna.jones@ukhsa.gov.uk.

Stephanie J Wright (SJ)

Environmental Research Group, Imperial College London, United Kingdom; Health Protection Research Unit in Environmental Exposures and Health, United Kingdom.

Timothy W Gant (TW)

UK Health Security Agency. Toxicology Department, Harwell Campus, Oxfordshire, United Kingdom; Environmental Research Group, Imperial College London, United Kingdom; Health Protection Research Unit in Environmental Exposures and Health, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH